Discontinuation report AVANDAMET
| Report ID | 8081 |
| Drug Identification Number | 02248440 |
| Brand name | AVANDAMET |
| Common or Proper name | Rosiglitazone maleate and metformin hydrochloride tablet |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | METFORMIN HYDROCHLORIDE ROSIGLITAZONE |
| Strength(s) | 1000MG 2.00MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100s |
| ATC code | A10BD |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2017-04-20 |
| Remaining supply date | 2017-10-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2017-04-26 | French | Compare |
| v5 | 2017-04-26 | English | Compare |
| v4 | 2017-04-25 | French | Compare |
| v3 | 2017-04-25 | English | Compare |
| v2 | 2017-04-25 | French | Compare |
| v1 | 2017-04-25 | English | Compare |
Showing 1 to 6 of 6